指南与共识重症综合管理与镇静镇痛呼吸衰竭与机械通气复苏、休克与脓毒症

拯救脓毒症运动:2019冠状病毒病(COVID-19)重症成人管理指南

Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19).
指南 / 共识 · Crit Care Med · 2020-01-01
一句话结论拯救脓毒症运动专家组针对COVID-19重症成人发布54条声明,涵盖感染控制、实验室诊断、血流动力学支持、通气支持和COVID-19治疗,其中9条强推荐、35条弱推荐、4条最佳实践声明。

该指南由来自12个国家的36名专家组成专家组,围绕ICU内COVID-19管理提出53个问题,检索直接与间接证据(多数支持治疗问题有近期系统评价),采用GRADE方法评估证据确定性,并综合获益与危害、资源与成本、公平性和可行性生成推荐。最终发布54条声明:4条最佳实践声明、9条强推荐、35条弱推荐,6个问题未提供推荐。主题包括感染控制、实验室诊断与标本、血流动力学支持、通气支持和COVID-19治疗。

要点

  • 专家组由12个国家36名专家组成,围绕ICU内COVID-19管理提出53个问题,最终发布54条声明。
  • 54条声明中4条为最佳实践声明、9条为强推荐、35条为弱推荐,6个问题未提供推荐。
  • 推荐覆盖五大主题:感染控制、实验室诊断与标本、血流动力学支持、通气支持和COVID-19治疗。
  • 证据确定性采用GRADE方法评估,推荐基于获益与危害、资源与成本、公平性和可行性的平衡生成。
  • 指南将根据新证据在后续版本中更新。

适用人群与场景

  • ICU内重症COVID-19成人患者。

研究设计与关键结果

  • 专家组由12个国家36名专家组成,所有成员完成世界卫生组织利益冲突声明表。
  • 专家组提出53个与ICU内COVID-19管理相关的问题,检索直接与间接证据,多数支持治疗问题有近期相关系统评价。
  • 采用GRADE方法评估证据确定性,基于获益与危害、资源与成本、公平性和可行性的平衡生成推荐。
  • 共发布54条声明:4条最佳实践声明、9条强推荐、35条弱推荐;6个问题未提供推荐。
  • 主题包括:1)感染控制,2)实验室诊断与标本,3)血流动力学支持,4)通气支持,5)COVID-19治疗。

证据类型、等级与局限

  • 证据类型:指南(拯救脓毒症运动COVID-19指南)。
  • 证据分级体系:GRADE方法评估证据确定性,推荐分为强推荐、弱推荐或最佳实践声明。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该指南为ICU内COVID-19重症成人管理提供54条声明,覆盖感染控制、实验室诊断与标本、血流动力学支持、通气支持和COVID-19治疗五个方面。
  • 原文未据此给出推荐。

指南或共识出处

  • 拯救脓毒症运动(Surviving Sepsis Campaign)COVID-19指南,发表于Critical Care Medicine。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a rapidly spreading illness, Coronavirus Disease 2019 (COVID-19), affecting thousands of people around the world. Urgent guidance for clinicians caring for the sickest of these patients is needed.

METHODS: We formed a panel of 36 experts from 12 countries. All panel members completed the World Health Organization conflict of interest disclosure form. The panel proposed 53 questions that are relevant to the management of COVID-19 in the ICU. We searched the literature for direct and indirect evidence on the management of COVID-19 in critically ill patients in the ICU. We identified relevant and recent systematic reviews on most questions relating to supportive care. We assessed the certainty in the evidence using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach, then generated recommendations based on the balance between benefit and harm, resource and cost implications, equity, and feasibility. Recommendations were either strong or weak, or in the form of best practice recommendations.

RESULTS: The Surviving Sepsis Campaign COVID-19 panel issued 54 statements, of which four are best practice statements, nine are strong recommendations, and 35 are weak recommendations. No recommendation was provided for six questions. The topics were: 1) infection control, 2) laboratory diagnosis and specimens, 3) hemodynamic support, 4) ventilatory support, and 5) COVID-19 therapy.

CONCLUSION: The Surviving Sepsis Campaign COVID-19 panel issued several recommendations to help support healthcare workers caring for critically ill ICU patients with COVID-19. When available, we will provide new evidence in further releases of these guidelines.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Alhazzani W, Møller MH, Arabi YM, et al. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19). Crit Care Med. 2020. PMID: 32224769. doi:10.1097/CCM.0000000000004363

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。